HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lectin staining of neoplastic and normal background colorectal mucosa in nonpolyposis and polyposis patients.

Abstract
A lectin histochemistry approach was adopted for comparative assessment of a colon cancer risk. Binding of Ulex europaeus agglutinin-I (UEA-I), peanut agglutinin (PNA), Griffonia simplicifolia agglutinin-II (GSA-II), and Dolichos biflorus agglutinin (DBA) was investigated in tumor and background tissue from a total of 34 adenoma and 44 cancer patients and compared with reaction patterns in control and familial adenomatous polyposis (FAP) patients. Adenoma patients with UEA-I positive rectal mucosa were found to have a 33.3 percent familial history of large bowel cancer, which was significantly higher (P less than 0.05) than the respective 4.0 percent figure for patients with negative rectal mucosa. In the cancer patients, an even stronger correlation was noted, with a 63.2 percent UEA-I positive family history association being recorded, as opposed to 4.0 percent in the negative rectal mucosa patients (P less than 0.01). Thus, the results suggest that, apparently, normal rectal background mucosa of individuals genetically at high risk for colon and rectal cancer demonstrates a specific lectin binding ability similar to that of FAP patients and that the simple method using UEA-I staining of rectal biopsy specimens can be of practical use in identification of high-risk colorectal cancer.
AuthorsT Kuroki, A Kubota, Y Miki, T Yamamura, J Utsunomiya
JournalDiseases of the colon and rectum (Dis Colon Rectum) Vol. 34 Issue 8 Pg. 679-84 (Aug 1991) ISSN: 0012-3706 [Print] United States
PMID1713144 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Lectins
Topics
  • Adenoma (diagnosis)
  • Adenomatous Polyposis Coli (diagnosis)
  • Adult
  • Aged
  • Biomarkers, Tumor (analysis)
  • Colorectal Neoplasms (diagnosis)
  • Female
  • Humans
  • Intestinal Mucosa (chemistry)
  • Lectins
  • Male
  • Middle Aged
  • Risk Factors
  • Staining and Labeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: